SBIO vs. ARKG ETF Comparison

Comparison of ALPS Medical Breakthroughs ETF (SBIO) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$37.19

Average Daily Volume

8,401

Number of Holdings *

83

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.31

Average Daily Volume

2,216,483

Number of Holdings *

34

* may have additional holdings in another (foreign) market
Performance
Period SBIO ARKG
30 Days -5.42% -4.11%
60 Days -4.19% -11.01%
90 Days 2.30% -10.33%
12 Months 47.72% -13.96%
3 Overlapping Holdings
Symbol Grade Weight in SBIO Weight in ARKG Overlap
ARCT F 0.31% 3.19% 0.31%
CMPS F 0.23% 0.75% 0.23%
NTLA F 0.94% 3.89% 0.94%
SBIO Overweight 80 Positions Relative to ARKG
Symbol Grade Weight
CORT B 3.66%
KRYS C 3.39%
RNA C 3.29%
ACLX C 3.19%
ALKS C 3.15%
CRNX B 2.95%
IMVT F 2.66%
DNLI D 2.36%
MRUS F 2.21%
AGIO C 2.05%
PTCT B 2.02%
XENE D 2.01%
VRNA A 1.98%
FOLD F 1.95%
EWTX C 1.92%
ACAD C 1.89%
VERA C 1.82%
ZLAB C 1.79%
VCEL A 1.73%
PTGX D 1.61%
CGON F 1.57%
IDYA F 1.53%
GERN C 1.48%
MIRM B 1.47%
KROS D 1.4%
LBPH A 1.4%
AKRO C 1.32%
MNKD B 1.26%
IRON B 1.21%
GLPG F 1.19%
TARS C 1.16%
IMCR C 1.07%
CLDX D 1.06%
ARVN F 1.06%
BCRX D 0.99%
XNCR B 0.98%
RCUS F 0.95%
SNDX F 0.93%
SPRY C 0.88%
VRDN D 0.84%
KURA F 0.83%
DAWN D 0.82%
AUPH C 0.78%
PHVS D 0.76%
APLT B 0.72%
COGT D 0.69%
ETNB D 0.57%
LQDA F 0.54%
PLRX D 0.53%
PRTA F 0.52%
ERAS C 0.51%
REPL C 0.5%
IRWD F 0.44%
AVXL B 0.42%
ANNX F 0.4%
MLYS F 0.39%
ALT C 0.37%
OLMA F 0.37%
ANAB F 0.36%
FLGT F 0.35%
ALLO F 0.35%
CELC F 0.34%
YMAB F 0.34%
URGN F 0.34%
SVRA F 0.34%
FULC F 0.33%
TBPH B 0.32%
FDMT F 0.31%
GHRS B 0.31%
AURA C 0.3%
ALEC F 0.28%
ACIU D 0.22%
VNDA C 0.2%
ITOS F 0.19%
STRO F 0.17%
ALDX D 0.17%
ZNTL D 0.17%
ENTA F 0.14%
INZY F 0.12%
HLVX F 0.06%
SBIO Underweight 31 Positions Relative to ARKG
Symbol Grade Weight
TWST F -8.37%
RXRX D -7.42%
CRSP D -7.34%
ADPT C -5.03%
CDNA D -4.77%
VCYT B -4.51%
SDGR C -4.14%
BEAM D -4.01%
IONS F -3.85%
NTRA A -3.82%
NRIX C -3.78%
TXG F -3.56%
GH B -3.49%
PSNL D -2.7%
ABSI F -2.19%
PACB D -2.16%
BFLY A -1.71%
VEEV C -1.7%
AMGN D -1.68%
ACCD F -1.47%
VRTX D -1.29%
ILMN C -1.25%
CERS D -1.18%
INCY C -1.11%
REGN F -0.92%
PRME F -0.9%
MASS F -0.69%
QSI B -0.68%
EXAS D -0.65%
RPTX F -0.64%
MRNA F -0.01%
Compare ETFs